| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Vera Therapeutics, Inc. (VERA) have been net sellers, shedding 37,000 shares worth roughly $1.3M on balance.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 235.2K | $7.22M | - | |
| CFO | 114.2K | $3.51M | - | |
| VP | 80.8K | $2.48M | - | |
| Other | 64.2K | $1.97M | - | |
| Other | 50.9K | $1.56M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 23, 2026 | Sean Grant56 | Chief Financial Officer | Sell | 4,949 | $41.98 | $207,778.32 | -4.2% | -18.4% | - | |
| Feb 23, 2026 | Marshall Fordyce74 | President and CEO | Sell | 16,925 | $41.98 | $710,577.51 | -6.2% | -18.4% | - | |
| Feb 23, 2026 | Robert Brenner | Chief Medical Officer | Sell | 2,151 | $41.98 | $90,307.37 | -4.1% | -18.4% | - | |
| Dec 15, 2025 | William D. Turner60 | Chief Regulatory Officer | Sale+OE10b5-1 | 10,000 | $50.08 | $500,767.00 | -30.8% | -18.6% | - | |
| Dec 11, 2025 | Patrick G Enright71 | Director | Buy | 5,882 | $42.50 | $249,985.00 | New | -8.6% | - | |
| Dec 8, 2025 | William D. Turner60 | Chief Regulatory Officer | Sale+OE10b5-1 | 10,000 | $45.31 | $453,053.00 | -30.8% | -13.5% | - | |
| Dec 3, 2025 | William D. Turner60 | Chief Regulatory Officer | Sale+OE10b5-1 | 10,000 | $40.00 | $400,000.00 | -30.8% | -4.8% | - | |
| Nov 21, 2025 | Jason S Carter | Chief Legal Officer | Sell | 3,864 | $27.82 | $107,498.03 | -7.3% | +48.1% | - | |
| Nov 11, 2025 | Joseph R Young61 | SVP, Finance, Chief Acct Officer | Sale+OE | 15,000 | $29.06 | $435,874.50 | -23.9% | +47.6% | - | |
| Jun 24, 2025 | Patrick G Enright71 | Director | Buy | 250,000 | $21.11 | $5,277,311.42 | +7.5% | +15.6% | - |